|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00006137 |
|
Date of registration:
|
03/08/2000 |
|
Primary sponsor: |
|
|
Public title:
|
Pilot Study of Enalapril and Renal Function in Patients With IgA Nephropathy
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
May 2000 |
|
Target sample size:
|
43 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00006137 |
|
Study type:
|
Interventional |
|
Study design:
|
Primary Purpose: Treatment
|
|
|
Contacts
|
|
Name:
|
Bryan D. Myers |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Stanford University |
| | |
|
Key inclusion & exclusion criteria
|
Histologically confirmed IgA nephropathy, diagnosed within the past 3 years
Clinical presentation of either isolated hematuria/proteinuria for less than 3 years OR
Acute nephritic or nephrotic syndrome
No secondary forms of IgA nephropathy associated with chronic inflammatory disease of the
bowel and liver
No end stage renal failure as defined by the following: Glomerular filtration rate less
than 15 mL/min AND Extensive glomerulosclerosis and tubulointerstitial damage
No systemic lupus erythematosus or systemic (extrarenal) vasculitis (Henoch-Schonlein
syndrome)
Healthy volunteers will be accrued as a control group
No other concurrent medical or psychiatric illness that would preclude study
Age minimum:
13 Years
Age maximum:
60 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
IGA Glomerulonephritis
|
|
Intervention(s)
|
|
Drug: enalapril
|
|
Secondary ID(s)
|
|
199/15244
|
|
SUMC-GCRC-5R01DK49372
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|